Bender James G. Insider Trades

Insider Trading History

Track insider trading activity for Bender James G.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Vice President - Manufacturing
Holding Value $114k 30,000 shares
Last Trade
Mar 11, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$152k 30,000 shares
$5.05
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Vice President, Manufacturing
Holding Value $105k 27,622 shares
Last Trade
Dec 28, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$209k 27,622 shares
$7.58
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Vice President, Manufacturing
Holding Value $336k 88,726 shares
Last Trade
Sep 30, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$64.9k 11,274 shares
$5.76
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Vice President, Manufacturing
Holding Value $177k 46,666 shares
Last Trade
Dec 05, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$292k 46,666 shares
$6.25
$3.79
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Vice President, Manufacturing
Holding Value $379k 100,000 shares
Last Trade
Jan 06, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.92M 200,000 shares
$9.60
$3.79
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $20 100 shares
Last Trade
Aug 29, 2013 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $0 0 shares
Last Trade
Aug 28, 2013 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $1.2k 6,000 shares
Last Trade
Aug 28, 2013 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $16k 80,000 shares
Last Trade
Mar 07, 2013 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $15k 75,000 shares
Last Trade
Jun 11, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $1.23k 6,179 shares
Last Trade
Jun 01, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
VP Product Development & Mfg.
Holding Value $1.27k 6,379 shares
Last Trade
Jun 01, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $1.57k 7,879 shares
Last Trade
May 31, 2012 Sale (Open Market)Shares sold on the open market or in a private sale.
No data
No data
$0.20
ImmunoCellular Therapeutics,
ImmunoCellular Therapeutics, IMUC
Vp, Product Development & Mfg.
Holding Value $2.93k 14,679 shares
Last Trade
May 25, 2012 Sale
No data
No data
$0.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up